The variant affects gene MFSD11, SRSF2 (major facilitator superfamily domain containing 11| serine and arginine rich splicing factor 2), which is on Chromosome 17. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary.
Pathogenic; Atypical chronic myeloid leukemia, BCR-ABL1 negative